Ellen Jones, MD, PhD

Articles by Ellen Jones, MD, PhD

Management of Triple-Negative Breast Cancer in Older Patients: How Is It Different?

ByShlomit Strulov Shachar, MD,Trevor A. Jolly, MBBS,Ellen Jones, MD, PhD,Hyman B. Muss, MD

February 15th 2018

In this review, we will discuss the role of geriatric assessment, alternative treatment modalities for older women with triple-negative breast cancer, and other special considerations for this patient population.

Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the Pond

ByMichael J. Eblan, MD,Noam A. VanderWalde, MD,Elaine M. Zeman, PhD,Ellen Jones, MD, PhD

June 15th 2014

In this review we discuss the rationale and underlying radiobiologic concepts for hypofractionation, and review the clinical trials and ASTRO guidelines supporting hypofractionated radiation in the treatment of breast cancer.

Adjuvant Therapy of Breast Cancer in Women 70 Years of Age and Older: Tough Decisions, High Stakes

ByEllen Jones, MD, PhD,Ashley Leak, PhD, RN-BC,Hyman B. Muss, MD

September 12th 2012

In this review we will discuss how to evaluate older breast cancer patients, including estimating survival, defining functional limitations, and providing guidelines for optimal adjuvant therapies.

Ellen Jones, MD, PhD

Articles by Ellen Jones, MD, PhD

Management of Triple-Negative Breast Cancer in Older Patients: How Is It Different?

Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the Pond

Adjuvant Therapy of Breast Cancer in Women 70 Years of Age and Older: Tough Decisions, High Stakes

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Dato-DXd for Metastatic Triple-Negative Breast Cancer

Data Readouts to Watch at the 2026 ASCO Annual Meeting

Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer

Osteosarcoma Drug Earns Rare Pediatric Disease, Orphan Drug Designations

Sacituzumab Tirumotecan Meets PFS End Point as 1L Option in Advanced TNBC